About this trial
This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men/women), age categories, mode of admission, and comorbidities.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Man or women aged 18 years and older.
Patients with acute dyspnea managed by a medical emergency team at the investigator centers between 2010 and 2021.
Disqualifiers
None
Trial population
Adult patients treated in the emergency department for acute dyspnea.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
All-cause post-hospitalization mortality and rehospitalization
Composite endpoint of all-cause post-hospitalization mortality and rehospitalization
Secondary outcomes
Proportion of readmissions (all-cause and specific - including hospitalization for acute dyspnea ).
Post admission mortality
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term). with outcome 5.
Post admission rehospitalization
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term) with outcome with outcome 4.
Erroneous etiological diagnosis of dyspnea in the emergency department
Assessed by: defined as a discrepancy between the diagnosis at discharge from the emergency department and the final diagnosis in the hospital discharge letter
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Pr. Nicolas GIRERD
Lead sponsor
Central Hospital, Nancy, France
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: